Literature DB >> 3137454

Physicochemical characterization of photoaffinity-labeled angiotensin II receptors.

M C Carson1, C M Harper, A J Baukal, G Aguilera, K J Catt.   

Abstract

Specific receptor sites for angiotensin II (AII) were analyzed in the adrenal cortex and other target tissues including liver, anterior pituitary gland, and smooth muscle, after covalent labeling with the radioactive photoaffinity analog 125I-[Sar1,(4-N3)Phe8]-AII. The photoreactive AII derivative retained high affinity for adrenal receptors and full steroidogenic activity in adrenal glomerulosa cells. In bovine adrenal cortex, covalent labeling of AII receptors by the photoreactive analog was specifically inhibited by [Sar1]AII with an IC50 of about 5 nM. The Mr of the covalent AII-receptor complex during polyacrylamide gel electrophoresis of the labeled protein under reducing conditions was 58,000. Under non-reducing conditions, a minor band with Mr of 105,000 was also observed. Two labeled species were also found during gel permeation chromatography of the detergent-solubilized complex, with Mrs of 64,000 and 86,000. The pl of the solubilized photolabeled complex was absorbed to wheat germ lectin Sepharose 6MB and could be eluted by N-acetylglucosamine. The Mrs of specific AII-binding sites in several target tissues, determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, showed target tissues, determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, showed significant differences within and between species. The most striking differences were between rat adrenal cortex (79,000) and both rat liver (60,000) and bovine adrenal cortex (58,000). After enzymatic deglycosylation, the Mr of the major component present in the bovine and rat adrenal cortex decreased by 40% and 55% to 35,000 and 34,000, respectively, suggesting that variations in carbohydrate content contribute to the physical heterogeneity of AII receptors in individual target tissues.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3137454     DOI: 10.1210/mend-1-2-147

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  8 in total

1.  Hydrodynamic properties of the angiotensin II receptor from bovine adrenal zona glomerulosa.

Authors:  J J Rondeau; N McNicoll; E Escher; S Meloche; H Ong; A De Léan
Journal:  Biochem J       Date:  1990-06-01       Impact factor: 3.857

2.  Properties of angiotensin II receptors in glial cells from the adult corpus callosum.

Authors:  C Matute; L Pulakat; C Río; C Valcárcel; R Miledi
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

3.  Deglycosylation and fragmentation of purified rat liver angiotensin II receptor: application to the mapping of hormone-binding domains.

Authors:  F Desarnaud; J Marie; C Lombard; R Larguier; R Seyer; T Lorca; S Jard; J C Bonnafous
Journal:  Biochem J       Date:  1993-01-01       Impact factor: 3.857

4.  N-glycosylation requirements for the AT1a angiotensin II receptor delivery to the plasma membrane.

Authors:  B Deslauriers; C Ponce; C Lombard; R Larguier; J C Bonnafous; J Marie
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

5.  Preliminary biochemical characterization of the novel, non-AT1, non-AT2 angiotensin binding site from the rat brain.

Authors:  Vardan T Karamyan; Jason Arsenault; Emanuel Escher; Robert C Speth
Journal:  Endocrine       Date:  2010-04-13       Impact factor: 3.633

6.  Analysis of the role of N-glycosylation in cell-surface expression and binding properties of angiotensin II type-2 receptor of rat pheochromocytoma cells.

Authors:  G Servant; D T Dudley; E Escher; G Guillemette
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

7.  Purification and characterization of angiotensin II AT2 receptors from neonatal rat kidney.

Authors:  G M Ciuffo; F M Heemskerk; J M Saavedra
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

8.  Receptor oligomerization: from early evidence to current understanding in class B GPCRs.

Authors:  Stephanie Y L Ng; Leo T O Lee; Billy K C Chow
Journal:  Front Endocrinol (Lausanne)       Date:  2013-01-04       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.